| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/24/2005 | US20050260581 Gonococcal proteins and nucleic acids |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260578 Antisense modulation of cellular apoptosis susceptibity gene expression |
| 11/24/2005 | US20050260575 Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ror receptor |
| 11/24/2005 | US20050260573 Novel processes for non-linearly amplifying nucleic acids using a primer with three segments |
| 11/24/2005 | US20050260572 Method of predicting cancer |
| 11/24/2005 | US20050260571 Human serpin |
| 11/24/2005 | US20050260567 NS5A nucleotide sequence variation as a marker for interferon response |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260564 Non-cytotoxic oriP replicon |
| 11/24/2005 | US20050260562 Oligonucleotides for use in determining the presence of human papilloma virus in a test sample |
| 11/24/2005 | US20050260556 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders |
| 11/24/2005 | US20050260276 Methods and articles for the delivery of therapeutic agents |
| 11/24/2005 | US20050260270 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo |
| 11/24/2005 | US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260223 Salmonella vaccine materials and methods |
| 11/24/2005 | US20050260220 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 11/24/2005 | US20050260198 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 11/24/2005 | US20050260184 Dual roles of pepper esterase as a biocontrol agent |
| 11/24/2005 | US20050260180 Materials and methods for treating vascular leakage in the eye |
| 11/24/2005 | US20050260177 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 11/24/2005 | US20050260176 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 11/24/2005 | US20050260169 Treatment of cancer using HSV mutant |
| 11/24/2005 | US20050260168 Compositions comprising viruses and methods for concentrating virus preparations |
| 11/24/2005 | US20050260167 Suppressing growth of pancreatic tumors or cancer cells having a K-ras gene point mutation by administering directly to the tumor cells an adenoviral vector having a DNA sequence encoding human interferon alpha and linked to a promoter and an antisense K-ras expressing vector |
| 11/24/2005 | US20050260166 Expressional enhancers from viruses |
| 11/24/2005 | US20050260165 HS-40 enhancer-containing vector |
| 11/24/2005 | US20050260164 Gene regulation with aptamer and modulator complexes for gene therapy |
| 11/24/2005 | US20050260163 Triplex hairpin ribozyme |
| 11/24/2005 | US20050260162 Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
| 11/24/2005 | US20050260160 use of gene therapy in the treatment of aseptic loosening of orthopaedic prostheses; adenoviral vectors and prodrugs are used for simultaneous, separate or sequential destruction of interface tissue allowing subsequent recementing of loose prostheses in a minimally invasive manner |
| 11/24/2005 | US20050260159 contacting a collagenase-producing cell in a tissue with an intracellular IL-1 receptor antagonist peptide to inhibit tissue destruction, thus inhibiting inflammatory diseses e.g. rheumatoid arthritis, degenerative intervertebral disc disease and chronic skin ulcers; inhibitor of matrix metalloproteinase |
| 11/24/2005 | US20050260157 Method and agent for treating vulnerable plaque |
| 11/24/2005 | US20050260156 Modified vaccinia virus ankara for the vaccination of neonates |
| 11/24/2005 | US20050260154 G-CSF analog compositions and methods |
| 11/24/2005 | US20050260124 Method of diagnosing risk of myocardial infarction |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | US20050257905 Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 11/24/2005 | DE102004021780A1 Verfahren und Anordnung zur DNA-Isolierung mit Trockenreagenzien Method and apparatus for DNA isolation with dry reagents |
| 11/24/2005 | DE102004021707A1 Verfahren zur Isolierung von spezifischen Molekülen, die hochselektiv an ausgewählte Zielmoleküle binden Method for the isolation of specific molecules that bind with high selectivity to selected target molecules |
| 11/24/2005 | CA2852855A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2837792A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2826522A1 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2816163A1 Methods and kits to detect hereditary angioedema type iii |
| 11/24/2005 | CA2812040A1 Antibodies |
| 11/24/2005 | CA2762011A1 Compositions and methods for control of insect infestations in plants |
| 11/24/2005 | CA2693280A1 Compositions and methods for control of insect infestations in plants |
| 11/24/2005 | CA2567301A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 11/24/2005 | CA2567109A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 11/24/2005 | CA2566519A1 Micrornas and uses thereof |
| 11/24/2005 | CA2566517A1 Improved konjac glucomannan cellulase hydrolysate prebiotics |
| 11/24/2005 | CA2566305A1 Antibodies |
| 11/24/2005 | CA2566292A1 Mucin3 egf-like domains |
| 11/24/2005 | CA2566257A1 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| 11/24/2005 | CA2565069A1 Biological bar code |
| 11/24/2005 | CA2564934A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | CA2564624A1 Novel nucleic acid sequences and their use in methods for achieving a pathogenic resistance in plants |
| 11/24/2005 | CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2563623A1 Carotenoid biosynthesis inhibitor resistance genes and methods of use in plants |
| 11/24/2005 | CA2563434A1 Methods for modifying plant characteristics |
| 11/24/2005 | CA2563396A1 Method of using adenoviral vectors to induce an immune response |
| 11/24/2005 | CA2563311A1 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | CA2562788A1 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
| 11/24/2005 | CA2562171A1 Mutant .alpha.-amylases |
| 11/24/2005 | CA2562022A1 Compositions and methods for control of insect infestations in plants |
| 11/24/2005 | CA2560108A1 Immunostimulatory nucleic acids for inducing il-10 responses |
| 11/23/2005 | EP1598431A1 Method of detecting chlamydia trachomatis and kit therefor |
| 11/23/2005 | EP1598430A1 METHOD OF EVALUATING BEEF TASTE, TEXTURE AND SO ON BASED ON STEAROYL-CoA DESATURASE GENOTYPE |
| 11/23/2005 | EP1598425A1 Modified Vaccinia Ankara virus variant |
| 11/23/2005 | EP1598424A1 Paramyxovirus vector encoding ribozyme and utilization thereof |
| 11/23/2005 | EP1598423A1 Herbicide resistant plant |
| 11/23/2005 | EP1598422A2 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 11/23/2005 | EP1598421A2 Oligoribonucleotides for influencing hair growth |
| 11/23/2005 | EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 11/23/2005 | EP1598416A1 Method for producing L-amino acid |
| 11/23/2005 | EP1598368A1 Anti-pci neutralizing antibody |
| 11/23/2005 | EP1598367A1 Modified coagulation factors with enhanced stability and their derivatives |
| 11/23/2005 | EP1598364A1 Chimerical soluble hyper IL-11 receptor and use thereof |
| 11/23/2005 | EP1598363A1 Protein regulating the concentration of calcium in endoplasmic reticulum |
| 11/23/2005 | EP1598362A2 Chlamidya trachomatis antigens |
| 11/23/2005 | EP1597395A2 Method for producing second-generation library |
| 11/23/2005 | EP1597394A2 A method for obtaining structural information about an encoded molecule |
| 11/23/2005 | EP1597387A1 Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same |
| 11/23/2005 | EP1597382A2 Genetically modified non-human mammals and cells |
| 11/23/2005 | EP1597381A2 Production of modified glycoproteins having multiple antennary structures |
| 11/23/2005 | EP1597380A2 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 11/23/2005 | EP1597379A2 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 11/23/2005 | EP1597378A2 Production of multimeric proteins |
| 11/23/2005 | EP1597377A2 Method of using adenoviral vectors with increased persistence in vivo |